Search Results - "Izquierdo Alonso, José Luis"

Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD) by Izquierdo-Alonso, José Luis, Rodriguez-GonzálezMoro, Jose Miguel, de Lucas-Ramos, Pilar, Unzueta, Irune, Ribera, Xabier, Antón, Esther, Martín, Antonio

“…Summary Aim To determine the prevalence and analyze the most relevant clinical characteristics of three clinical phenotypes of COPD: emphysema (type 1),…”
Get full text

N-acetylcysteine for prevention and treatment of COVID-19: Current state of evidence and future directions by Izquierdo-Alonso, José Luis, Pérez-Rial, Sandra, Rivera, Carolina Gotera, Peces-Barba, Germán

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19) and can be associated with serious…”
Get full text

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials by Fabbri, Leonardo M, Prof, Calverley, Peter MA, Prof, Izquierdo-Alonso, José Luis, MD, Bundschuh, Daniela S, PhD, Brose, Manja, MSc, Martinez, Fernando J, Prof, Rabe, Klaus F, Prof

“…Summary Background Patients with chronic obstructive pulmonary disease (COPD) have few options for treatment. The efficacy and safety of the…”
Get full text

Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study by Sicras-Mainar, Antoni, de Abajo, Francisco J, Izquierdo-Alonso, José Luis

“…To determine the clinical and economic consequences of inhaled corticosteroid doses and particle size in patients on triple-inhalation therapy for COPD…”
Get full text

Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective by Schroeder, Melanie, Benjamin, Nicole, Atienza, Laura, Biswas, Chandroday, Martin, Alan, Whalen, John D, Izquierdo Alonso, José Luis, Riesco Miranda, Juan Antonio, Soler-Cataluña, Juan José, Huerta, Alicia, Ismaila, Afisi S

“…To evaluate the cost-effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) vs twice-daily budesonide/formoterol (BUD/FOR) in…”
Get full text

Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases by Chiner-Vives, Eusebi, Cordovilla-Pérez, Rosa, de la Rosa-Carrillo, David, García-Clemente, Marta, Izquierdo-Alonso, José Luis, Otero-Candelera, Remedios, Pérez-de Llano, Luis, Sellares-Torres, Jacobo, de Granda-Orive, José Ignacio

“…On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic. Till now, it affected 452.4 million (Spain, 11.18…”
Get full text

Cost-effectiveness analysis of anti-IL-5 therapies of severe eosinophilic asthma in Spain by González-Barcala, Francisco Javier, Muñoz-Gall, Xavier, Mariscal, Esther, García, Andrea, Yang, Shibing, van de Wetering, Gijs, Izquierdo-Alonso, José Luis

“…To analyse the cost-effectiveness of MEP with standard of care (SoC) versus other anti-IL-5 therapies approved for the treatment of severe eosinophilic asthma…”
Get more information

Epidemiology of Lung Cancer in Spain and Forecast for the Future by Hernández, Ignacio Sánchez, Izquierdo Alonso, José Luis, Sánchez, Carlos Almonacid

“…Lung cancer, a steadily growing problem, ranks as the first cause of tumor-related deaths in developed countries. the relation between lung cancer and smoking…”
Get full text

Type 2 Diabetes Mellitus, Glycated Hemoglobin Levels, and Cardiopulmonary Exercise Capacity in Patients With Ischemic Heart Disease by Uribe-Heredia, Giovanna, Arroyo-Espliguero, Ramón, Viana-Llamas, María Carmen, Piccone-Saponara, Luis Guillermo, Álvaro-Fernández, Henar, García-Magallón, Belén, Torán-Martínez, Claudio, Silva-Obregón, Alberto, Izquierdo-Alonso, José Luis

“…PURPOSE:Diabetes mellitus (DM) is associated with long-term cardiovascular complications, including ischemic heart disease (IHD). Nonetheless, DM may directly…”
Get full text

Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases by Del Pozo, Victoria, Bobolea, Irina, Rial, Manuel J, Espigol-Frigolé, Georgina, Solans Laqué, Roser, Hernández-Rivas, Jesús María, Mora, Elvira, Crespo-Lessmann, Astrid, Izquierdo Alonso, José Luis, Domínguez Sosa, María Sandra, Maza-Solano, Juan, Atienza-Mateo, Belén, Bañas-Conejero, David, Moure, Abraham L, Rúa-Figueroa, Íñigo

“…Eosinophil-related diseases represent a group of pathologic conditions with highly heterogeneous clinical presentation and symptoms ranging from mild to…”
Get full text

Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group by Calle Rubio, Myriam, López-Campos, José Luis, Izquierdo Alonso, José Luis, Martínez Pitarch, Dolores, Pascual, Milagros Iriberri, Navarrete, Bernardino Alcázar, Falcones, Manuel Valle, Inglés, María Jesús Avilés, López, Carlos Cabrera, Martínez, Carlos José Álvarez, Ruiz, Francisco Ortega, Golpe, Rafael, Gomila, Antònia Fuster, Guardia, Sergi Pascual, Miranda, Juan Antonio Riesco, Peces-Barba, Germán, García-Río, Francisco, Muñiz, Manuel Ángel Martínez, Cosío, Borja G.

Get full text

Economic impact of pulmonary drugs on direct costs of stable chronic obstructive pulmonary disease by Izquierdo-Alonso, José Luis, de Miguel-Díez, J

“…To assess the impact of prescribing pulmonary drugs according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines on direct costs…”
Get more information

Cardiovascular Risk Factors in Chronic Obstructive Pulmonary Disease: Results of the ARCE Study by de Lucas-Ramos, Pilar, Izquierdo-Alonso, José Luis, Moro, José Miguel Rodríguez-González, Bellón-Cano, José María, Ancochea-Bermúdez, Julio, Calle-Rubio, Myrian, Calvo-Corbella, Eduardo, Molina-París, Jesús, Pérez-Rodríguez, Esteban, Pons, Sonia

“…Cardiovascular disease is a common cause of death in patients with chronic obstructive pulmonary disease (COPD). It is not clear whether the high…”
Get full text

Defining the Profile of Obstructive Sleep Apnea in Women Compared to Men by Romero-Peralta, Sofia, García-Rio, Francisco, Resano Barrio, Pilar, Izquierdo Alonso, Jose Luis, Viejo-Ayuso, María Esther, Mediano San Andrés, Rosa, Silgado Martínez, Laura, Álvarez Balado, Leticia, Naval, Jorge Castelao, Fernández Francés, Jesús, Mediano, Olga

“…The importance of understanding the presentation of obstructive sleep apnea (OSA) in women has been increasingly recognized. Although there is some insight…”
Get more information

Analysis of the Ischemia-Modified Albumin as a Potential Biomarker for Cardiovascular Damage in Obstructive Sleep Apnea Patients with Acute Coronary Syndrome by Resano-Barrio, Pilar, Alfaro, Enrique, Solano-Pérez, Esther, Coso, Carlota, Cubillos-Zapata, Carolina, Díaz-García, Elena, Romero-Peralta, Sofía, Izquierdo-Alonso, Jose Luis, Barbé, Ferran, García-Rio, Francisco, Sánchez-de-la-Torre, Manuel, Mediano, Olga, On Behalf Of The Spanish Sleep Network

“…Obstructive sleep apnea (OSA) has been identified as a cardiovascular (CV) risk factor. The potential of OSA promoting the synthesis of CV biomarkers in acute…”
Get full text

Oral antibiotic treatment of exacerbation of COPD. Beyond COVID-19 by Rodríguez González-Moro, José Miguel, Izquierdo Alonso, José Luis

“…COPD (chronic obstructive pulmonary disease) includes patients with chronic bronchitis and / or emphysema who have in common the presence of a chronic and…”
Get full text

Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care by Alcázar Navarrete, Bernardino, Ancochea Bermúdez, Julio, García-Río, Francisco, Izquierdo Alonso, José Luis, Miravitlles, Marc, Rodríguez González-Moro, José Miguel, Soler-Cataluña, Juan José

“…OBJECTIVETo describe an evidence- and experience-based expert consensus on the most relevant issues of patients with COPD exacerbations. METHODSThe Delphi…”
Get full text

Asociación de factores de riesgo cardiovascular y EPOC. Resultados de un estudio epidemiológico (estudio ARCE) by de Lucas-Ramos, Pilar, Luis Izquierdo-Alonso, José, Rodríguez-González Moro, José Miguel, Bellón-Cano, José María, Ancochea-Bermúdez, Julio, Calle-Rubio, Myrian, Calvo-Corbella, Eduardo, Molina-París, Jesús, Pérez-Rodríguez, Esteban, Pons, Sonia

“…Objetivo La enfermedad cardiovascular es una causa de muerte frecuente en los pacientes con enfermedad pulmonar obstructiva crónica (EPOC). No está claro si el…”
Get full text

The role of vitamin D in chronic obstructive pulmonary disease, asthma and other respiratory diseases by García de Tena, Jaime, El Hachem Debek, Abdulkader, Hernández Gutiérrez, Cristina, Izquierdo Alonso, José Luis

“…There has been growing interest in recent years in the extraosseous effects of vitamin D. In this article, we review the physiology of vitamin D, the…”
Get full text

Pneumology in the Days of COVID-19 by Izquierdo Alonso, José Luis, Rodríguez González-Moro, José Miguel

Get full text